EM · Acute decompensated heart failure
Acute decompensated heart failure and cardiogenic pulmonary oedema
Also known as Acute pulmonary oedema · Cardiogenic pulmonary oedema · Acute heart failure · Flash pulmonary oedema
Acute decompensated heart failure and cardiogenic pulmonary oedema in the emergency department — the wet/dry × warm/cold bedside profiles (Nohria), natriuretic-peptide rule-out (Breathing Not Properly, PRIDE), oxygen and early NIV (ESC 2021, 3CPO, Cochrane), the IV loop diuretic with early response checks (DOSE, HFA, ADVOR), vasodilators when SBP is over 110 mmHg (Cotter), cardiogenic shock (SOAP II, OptimaCC, SCAI stages, CULPRIT-SHOCK, MCS trials), what not to do (morphine, ultrafiltration, renal-dose dopamine) and discharge (orthodema, STRONG-HF). ACEM-primary, globally tagged.
Checked against its sources on 8 Oct 2026
Practise this topic
On this page
Study tools
Your progress
Saved on this device.
Target exams
Red flags
- Respiratory distress (RR over 25, SpO2 under 90%) needs non-invasive positive pressure ventilation as soon as possible; intubate for progressive respiratory failure despite it
- IV vasodilators only when SBP is over 110 mmHg — the hypoperfused, hypotensive patient is in cardiogenic shock
- Morphine is not routine — in ADHERE it was an independent predictor of mortality
- Find the precipitant — in OPTIMIZE-HF the commonest identified were pneumonia/respiratory process, ischaemia and arrhythmia
- A normal chest X-ray does not exclude congestion — 20% of congested patients have one
Meet the patient
A 72-year-old man with known HFrEF sits bolt upright at 3am, saturations 84 per cent on room air, respiratory rate 34, BP 198/108 in fast atrial fibrillation, warm peripheries, raised JVP, crackles to the mid-zones. He missed his furosemide for three days. Respiratory rate over 25 and SpO2 under 90 per cent: NIV goes on now, and with an SBP well over 110 mmHg a vasodilator is an option.[1]
One decision gates every acute heart failure presentation: warm or cold? Read the profile at the bedside, treat to it, and find the precipitant in parallel.[7]
References30ShowHide
- [1]McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European heart journal, 2021.PMID 34447992
- [2]Gray A, Goodacre S, Newby DE, et al. Noninvasive ventilation in acute cardiogenic pulmonary edema. The New England journal of medicine, 2008.PMID 18614781
- [3]Felker GM, Lee KL, Bull DA, et al. Diuretic strategies in patients with acute decompensated heart failure. The New England journal of medicine, 2011.PMID 21366472
- [4]Chen HH, Anstrom KJ, Givertz MM, et al. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. JAMA, 2013.PMID 24247300
- [5]Cotter G, Metzkor E, Kaluski E, et al. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet (London, England), 1998.PMID 9482291
- [6]Mullens W, Damman K, Harjola VP, et al. The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology. European journal of heart failure, 2019.PMID 30600580
- [7]Nohria A, Tsang SW, Fang JC, et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. Journal of the American College of Cardiology, 2003.PMID 12767667
- [8]Berbenetz N, Wang Y, Brown J, et al. Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema. The Cochrane database of systematic reviews, 2019.PMID 30950507
- [9]Teerlink JR, Cotter G, Davison BA, et al. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet (London, England), 2013.PMID 23141816
- [10]Peacock WF, Hollander JE, Diercks DB, et al. Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis. Emergency medicine journal : EMJ, 2008.PMID 18356349
- [11]Bart BA, Goldsmith SR, Lee KL, et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. The New England journal of medicine, 2012.PMID 23131078
- [12]Thiele H, Zeymer U, Neumann FJ, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. The New England journal of medicine, 2012.PMID 22920912
- [13]De Backer D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock. The New England journal of medicine, 2010.PMID 20200382
- [14]Lala A, McNulty SE, Mentz RJ, et al. Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF). Circulation. Heart failure, 2015.PMID 26041600
- [15]Thiele H, Akin I, Sandri M, et al. PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock. The New England journal of medicine, 2017.PMID 29083953
- [16]Baran DA, Grines CL, Bailey S, et al. SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2019.PMID 31104355
- [17]Fonarow GC, Abraham WT, Albert NM, et al. Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF. Archives of internal medicine, 2008.PMID 18443260
- [18]Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. The New England journal of medicine, 2002.PMID 12124404
- [19]Januzzi JL Jr, Camargo CA, Anwaruddin S, et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. The American journal of cardiology, 2005.PMID 15820160
- [20]Thiele H, Jobs A, Ouweneel DM, et al. Percutaneous short-term active mechanical support devices in cardiogenic shock: a systematic review and collaborative meta-analysis of randomized trials. European heart journal, 2017.PMID 29020341
- [21]Levy B, Clere-Jehl R, Legras A, et al. Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction. Journal of the American College of Cardiology, 2018.PMID 29976291
- [22]Mullens W, Dauw J, Martens P, et al. Acetazolamide in Acute Decompensated Heart Failure with Volume Overload. The New England journal of medicine, 2022.PMID 36027559
- [23]Mullens W, Abrahams Z, Francis GS, et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. Journal of the American College of Cardiology, 2009.PMID 19215833
- [24]Prins KW, Neill JM, Tyler JO, et al. Effects of Beta-Blocker Withdrawal in Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis. JACC. Heart failure, 2015.PMID 26251094
- [25]Mebazaa A, Davison B, Chioncel O, et al. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial. Lancet (London, England), 2022.PMID 36356631
- [26]Thiele H, Zeymer U, Akin I, et al. Extracorporeal Life Support in Infarct-Related Cardiogenic Shock. The New England journal of medicine, 2023.PMID 37634145
- [27]Møller JE, Engstrøm T, Jensen LO, et al. Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock. The New England journal of medicine, 2024.PMID 38587239
- [28]Long B, Brady WJ, Gottlieb M Emergency medicine updates: Sympathetic crashing acute pulmonary edema. The American journal of emergency medicine, 2025.PMID 39799613
- [29]McDonagh TA, Metra M, Adamo M, et al. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European heart journal, 2023.PMID 37622666
- [30]Nohria A, Mielniczuk LM, Stevenson LW Evaluation and monitoring of patients with acute heart failure syndromes. The American journal of cardiology, 2005.PMID 16181821